opal 5 color fluorescent detection platform (Akoya Biosciences)
Akoya Biosciences is a verified supplier 
Akoya Biosciences manufactures this product 
86
Structured Review
Akoya Biosciences
opal 5 color fluorescent detection platform
Opal 5 Color Fluorescent Detection Platform, supplied by Akoya Biosciences, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/opal+platform/pm37005910-46-2-1
Average 86 stars, based on 1 article reviews
Opal 5 Color Fluorescent Detection Platform, supplied by Akoya Biosciences, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/opal+platform/pm37005910-46-2-1
Average 86 stars, based on 1 article reviews
opal 5 color fluorescent detection platform - by Bioz Stars,
2026-10
86/100 stars
Images
Related Articles
Staining:Article Title: Closer proximity of pre-treatment CD4 + T cells to CD8 + T cells favor response to neoadjuvant immunotherapy in patients with PD-L1 low-expressing non-small cell lung cancer Article Snippet: ffer. Tissue slides stained with TSA were counterstained with DAPI and mounted in antifade mounting medium. Comprehensive details on all primary antibodies and Opal used can be found in Table S1 . The Amplification:Article Title: Closer proximity of pre-treatment CD4 + T cells to CD8 + T cells favor response to neoadjuvant immunotherapy in patients with PD-L1 low-expressing non-small cell lung cancer Article Snippet: ffer. Tissue slides stained with TSA were counterstained with DAPI and mounted in antifade mounting medium. Comprehensive details on all primary antibodies and Opal used can be found in Table S1 . The Software:Article Title: Closer proximity of pre-treatment CD4 + T cells to CD8 + T cells favor response to neoadjuvant immunotherapy in patients with PD-L1 low-expressing non-small cell lung cancer Article Snippet: ffer. Tissue slides stained with TSA were counterstained with DAPI and mounted in antifade mounting medium. Comprehensive details on all primary antibodies and Opal used can be found in Table S1 . The Immunofluorescence:Article Title: Closer proximity of pre-treatment CD4 + T cells to CD8 + T cells favor response to neoadjuvant immunotherapy in patients with PD-L1 low-expressing non-small cell lung cancer Article Snippet: ffer. Tissue slides stained with TSA were counterstained with DAPI and mounted in antifade mounting medium. Comprehensive details on all primary antibodies and Opal used can be found in Table S1 . The Immunohistochemistry:Article Title: Closer proximity of pre-treatment CD4 + T cells to CD8 + T cells favor response to neoadjuvant immunotherapy in patients with PD-L1 low-expressing non-small cell lung cancer Article Snippet: ffer. Tissue slides stained with TSA were counterstained with DAPI and mounted in antifade mounting medium. Comprehensive details on all primary antibodies and Opal used can be found in Table S1 . The |